Arrowstreet Capital’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-223,990
| Closed | -$2.15M | – | 2074 |
|
2024
Q4 | $2.15M | Sell |
223,990
-127,376
| -36% | -$1.22M | ﹤0.01% | 1254 |
|
2024
Q3 | $1M | Buy |
+351,366
| New | +$1M | ﹤0.01% | 1385 |
|
2023
Q3 | – | Sell |
-99,598
| Closed | -$175K | – | 1460 |
|
2023
Q2 | $175K | Buy |
+99,598
| New | +$175K | ﹤0.01% | 1172 |
|
2023
Q1 | – | Sell |
-15,975
| Closed | -$85K | – | 1572 |
|
2022
Q4 | $85K | Hold |
15,975
| – | – | ﹤0.01% | 1295 |
|
2022
Q3 | $56K | Buy |
+15,975
| New | +$56K | ﹤0.01% | 1238 |
|